IR-Med (IRME) Debt to Equity (2020 - 2025)

IR-Med's Debt to Equity history runs 6 years deep, the most recent figure standing at -$0.28 for Q2 2025.

• In Q2 2025, Debt to Equity changed N/A year-over-year to -$0.28; the TTM figure through Jun 2025 stood at -$0.28 (changed N/A YoY), while the FY2024 annual figure was -$0.64, down 244.97% from the prior year.
• Debt to Equity came in at -$0.28 for Q2 2025 at IR-Med, up from -$0.32 in the prior quarter.
• In the past five years, Debt to Equity ranged from a high of $74.65 in Q4 2021 to a low of -$0.64 in Q4 2024.
• A 5-year average of $5.72 and a median of $0.05 in 2021 frame the typical range for Debt to Equity.
• Across the five-year window, Debt to Equity soared 62904.53% in 2021 and plunged 244.97% in 2024, its largest moves.
• IR-Med's Debt to Equity stood at $74.65 in 2021, then plunged by 99.9% to $0.08 in 2022, then surged by 466.0% to $0.44 in 2023, then tumbled by 244.97% to -$0.64 in 2024, then soared by 55.96% to -$0.28 in 2025.
• According to Business Quant data, Debt to Equity over the past three periods registered -$0.28, -$0.32, and -$0.64 for Q2 2025, Q1 2025, and Q4 2024 respectively.

Peer Comparison